ArticleERJ open research2026
Exhaled breath profiling for early silicosis detection in workers at risk: a pilot study.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Silicosis remains a major occupational health concern in respirable crystalline silica (RCS)-exposed workers. Exhaled breath analysis using volatile organic compound (VOC) profiling has emerged as a promising noninvasive approach for early disease detection. This feasibility study evaluated multicapillary column/ion mobility spectrometry (MCC/IMS)-based VOC profiling for differentiating silicosis from other respiratory conditions and healthy controls in an occupational health setting. Methods: We conducted a multicentre, cross-sectional observational study employing MCC/IMS to identify VOC patterns. Breath data were reduced to principal components and used in logistic lasso regression to develop predictive models. Internal and external validation assessed model performance, and subgroup analyses explored the impact of comorbidities and spirometry abnormalities. Results: A total of 185 participants were enrolled, including 24 COPD patients, 26 with benign asbestos-related diseases (BARD) and 32 with confirmed silicosis, alongside 25 healthy controls and 78 RCS-exposed controls. Silicosis was distinguished from BARD and COPD with 100% and 87.5% accuracy (area under the receiver operating characteristic curve (AUC Conclusion: MCC/IMS-based breath analysis shows promise as a rapid, portable and noninvasive technique for early detection of silicosis in RCS-exposed workers. Future research should validate these findings in larger cohorts, integrate cross-validation of candidate biomarkers across analytical platforms and establish standardised protocols to enable routine implementation in occupational health surveillance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.